Read + Share
Tambaro R, Calvanese G, Muto A, Formisano L, et al. Real-world outcomes of second-line pembrolizumab in urothelial carcinoma: a
multicenter analysis from the Campania Oncological Network (ROC). BMC Cancer 2026;26:956.
PMID: 42237111
|
 |
|
Tambaro R, Calvanese G, Muto A, Formisano L, et al. Real-world outcomes of second-line pembrolizumab in urothelial carcinoma: a
multicenter analysis from the Campania Oncological Network (ROC). BMC Cancer 2026;26:956.
PMID: 42237111
|
|
|
|